🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to learn about the effectiveness and treat...
Status
Completed
Location
Pfizer Norway
Start Date
2023-06-23
Trial ID
NCT05834348
SMARCA4 mutation is clinically known to be an independent poor prognostic f...
Status
Not Yet Recruiting
Location
The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, Fujian, China, 350025
Start Date
2025-08-20
Trial ID
NCT07093762
Treatments Being Tested
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
This study will evaluate the efficacy and safety of atezolizumab when given...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2020-04-09
Trial ID
NCT04194203
Treatments Being Tested
This first-in-human open-label, multicenter, dose-escalation and expansion ...
Status
Completed
Location
Honor Health Research Institute
Start Date
2016-05-23
Trial ID
NCT02794571
The main purpose of this study is to validate a safe dose of atezolizumab w...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2018-06-19
Trial ID
NCT03394885
Treatments Being Tested
This study will compare the efficacy and safety of molecularly-guided thera...
Status
Completed
Location
Blacktown Hospital
Start Date
2018-07-10
Trial ID
NCT03498521
This is a non-randomized, open-label, dose-escalation, and dose-expansion P...
Status
Active Not Recruiting
Location
Cancer Hospital of Shandong First Medical University
Start Date
2025-03-13
Trial ID
NCT06771622
This open-label, Phase Ib study that has six treatment arms is designed to ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2012-07-11
Trial ID
NCT01633970
This is a phase III, randomized, double-blinded, comparative, multi-centre ...
Status
Completed
Location
Krankenhaus der Barmherzigen Brüder Graz
Start Date
2016-09-22
Trial ID
NCT02891824